Strides Pharma Science Limited has informed the Exchange about Earnings Call to discuss the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Strides Pharma Science Limited has announced an earnings call scheduled for May 18, 2026 at 5:00 PM IST to discuss the company's audited financial results for Q4FY26 and the full financial year ended March 31, 2026. The conference call will feature Managing Director & Group CEO Badree Komandur and Group CFO Vikesh Kumar. The company filed this announcement with exchanges on May 11, 2026, providing dial-in details for investors and analysts to participate. The information will also be available on the company's website.
This is a routine disclosure announcing the timing of quarterly earnings discussion. The participation of both the CEO and CFO indicates the company will provide detailed commentary on Q4 and full-year performance. Investors should monitor the call for updates on business performance and guidance.